NXP Semiconductors NV【N1XP34】銘柄情報 | ADVFN

US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
ブラジル
BOV
NXP Semiconductors NV (N1XP34) 銘柄情報

NXP Semiconductors NV (N1XP34)

665.02

0.00

(0.00%)

終了 12月18日 5:55AM

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

665.02

買値

0.00

売値

0.00

出来高

-

0.00 日の範囲 0.00

515.11 52 週間の範囲 790.79

時価総額

前日終値

665.02

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

6

発行済株式数

257,190,000

配当利回り

1.77%

PER

16.29

1 株当たり利益 (EPS)

12.76

歳入

13.28B

純利益

3.28B

セクター

Semiconductor,related Device

業界

Semiconductor,related Device

ウェブサイト

www.nxp.com

本社

Eindhoven, North Brabant, Nld

設立

-

NXP Semiconductors NV is listed in the Semiconductor,related Device sector of the ボベスパ (ブラジル) with ticker N1XP34. The last closing price for NXP Semiconductors NV was R$665.02. Over the last year, NXP Semiconductors NV shares have traded in a share price range of R$ 515.11 to R$ 790.79.

NXP Semiconductors NV currently has 257,190,000 shares in issue. The market capitalisation of NXP Semiconductors NV is R$171.04 billion. NXP Semiconductors NV has a price to earnings ratio (PE ratio) of 16.29.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	3.37	0.509332728784	661.65	665.02	654.18	2	661.27	DR
4	37.41	5.96070808305	627.61	714.15	627.61	7	678.67711538	DR
12	22.5	3.50183651871	642.52	730.73	624.33	6	666.96526132	DR
26	-71.02	-9.64893212325	736.04	790.79	624.33	7	707.94174603	DR
52	146.02	28.1348747592	519	790.79	515.11	8	676.101832	DR
156	44.29	7.13514732653	620.73	790.79	370.18	806	463.88010605	DR
260	378.21	131.867787037	286.81	790.79	179.24	1058	464.13657654	DR

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
ATED3Atom Educacao E Editora S.A.	R$ 2.05 (39.46%)	267.1k
AGXY3Agrogalaxy Participacoes SA	R$ 0.50 (25.00%)	4.74M
DOTZ3Dotz S.A.	R$ 3.20 (18.96%)	68.4k
DASA11Diagnosticos da America S.A	R$ 1.08 (13.68%)	100
IFCM3Infracommerce Caxaas S.A.	R$ 0.09 (12.50%)	9.38M
COCE11Cia Energetica Ceara Coelce	R$ 0.39 (-35.00%)	11.7k
CRPG3TronoxPigmentos do Brasil S.A.	R$ 21.15 (-20.19%)	1.5k
QUAL3Qualicorp Consultoria e Corretora de Seguros S.A.	R$ 1.79 (-17.51%)	11.66M
EPAR3Embpar Participacoes S.A.	R$ 5.65 (-15.67%)	44.5k
AZEV3Azevedo Travassos Sa	R$ 1.07 (-13.71%)	1.29M
HAPV3Hapvida Participacoes Investimento SA	R$ 2.28 (-11.28%)	313.56M
COGN3CognaEducacao SA	R$ 1.09 (1.87%)	80.64M
BBDC4Bco Bradesco Sa	R$ 11.99 (0.756303%)	66.96M
ITSA4Itausa Investimentos Itau SA	R$ 9.04 (0.110742%)	52.07M
ITUB4Itau Unibanco Holding SA	R$ 31.88 (0.536108%)	40.11M

JMoneyHoops

JMoneyHoops 4分前

Verified profile! https://x.com/jmoney_hoops/status/1869205515588501520?s=46&t=EuLw-SVIgNfV5yGP5vc4tQ

dstock07734

dstock07734 4分前

KILLAZILLA

KILLAZILLA 5分前

DILUTION IS THE MAIN EYESORE....

WITHOUT SUBSTANTIAL REVENUE IT'S A POS DILUTION SCAM......

gitreal

gitreal 5分前

...where would our country be without folks daring to dream?

Pretty sad that you can't tell the difference between a grifting penny stock CEO and a legit startup entrepreneur. Or, even worse, you do know the difference and you are pretending, just to help promote the scam. I think i

flipper44

flipper44 6分前

Those people know we can still see them, right?

awesomed007

awesomed007 6分前

If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.

awesomed007

awesomed007 6分前

If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.

Eatatjoes

Eatatjoes 6分前

Paul Malec of Deer Park, NY

fuagf

Yeps, yeps and yeps. Good ones.

NoMoDo

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175527881 Meeting announced for TODAY

Better yet. Read this closely:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175530469
Ybyra agreed to purchase a company in France. Giving Dividends.

manibiotech

manibiotech 7分前

Well if you read the link you posted yourself , they are tracking in almost every other country on the planet . Please see the table . They are giving projected global scope of what is going on
I have no problem with you posting that link every hour of that pleases you

1vman

*****🚽UBQU🚽 Kevin Lamb is the typical OTC CEO , pocketing money while share holders lose amost all their investment

So much for forbes and da T0P 10 Health innovators wow!

🤔HUZZAH ENOUGH SAID !!!🤔

janice shell

janice shell 8分前

First of all, Syria is not a big oil producer. So it's a stupid idea. Trump has put it forward because he thinks everything should be his.

And because he's a moron.

https://investorshub.advfn.com/uimage/uploads/2024/12/17/oage%5BJPEG_image.jpeg

I must so

HappyAlways

HappyAlways 8分前

I am, as a Fannie shareholder, against any government action to dilute Fannie shareholders' interest. (1) The PSPA loan is no longer valid, given the NWS payments are way over the original 10% interest payments by $310B. (2) Any attempt to exercise the free warrant will be met with lawsuits, given t

TheDane

TheDane 9分前

Not only did it hold but it’s on the way back up.

OnTrack444

OnTrack444 9分前

Might see a dime after the RS!

If you think a 30B OS OTC stock is going to run from .0011 to .10 you're smoking something pretty whacky!! Find a low OS stock with catalysts in place and it's entirely possible but not this one my friend!!! GLTY

manibiotech

manibiotech 10分前

Interesting for sure but not conclusive which he repeat every day

But there are other things mentioned in that paragraph besides "Neuroscience" ( not Neuro-oncology). And there are other categories of vaccines in development even in neuroscience

FACT-MASTER

FACT-MASTER 11分前

Pivotal Study Design.

Through a meeting with the FDA, the Company obtained feedback on the potential registrational pathway following the Phase 1 ALLOHA trial. Based on this feedback, the Company believes that for a registrational trial: (1) the following proposed patient population i

arizona1

arizona1 11分前

Never trumpers are hilarious and brilliant too.

jimr1717

jimr1717 13分前

“ which now includes 17 issued U.S. patents and 84 pending”

It has taken them from $90,000 to $2 bucks in share price to get 17 of 101 patents.

There will be people that might need a million dollar share price to brake even by then.

This Fake it sham is

NoMoDo

NoMoDo 14分前

If we don't see a dime, I will be shocked.

Slyhunter

Slyhunter 14分前

I did Uber, when it was worth doing. Made, sometimes $300 a day at the b3e3ginning when they first started in my county, It was disastrous to not get out of the car and inspect the backseat to insure it was clean between fares, especially when driving dr8u8nks home at night. I don't see how Tesla is

nfrequent

nfrequent 14分前

Get ready. Phase One complete!!!
https://archive.fast-edgar.com/20241217/AP2Z522CZZ2R52V222JG2WY2CDQEZZ226L62/

XMaster2023

XMaster2023 14分前

Well now kinda sensitive. We can only talk about others tracking the approval one time because it doesn’t meet your short agenda? Funny how an American Society are tracking approval in the UK. They understand the approval will have a big impact on the gene therapy world. Your tacid comments will

NXP Semiconductors NV

Auren Energia ON

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約